LDHA is overexpressed in HPV16+ CIN patients, and GLUT1 expression is higher in CIN-stage I patients than in a control group, which further increases in CIN-II/III patients’ cancer cells. The gene discussed is SLC2A1; the disease is cervical squamous intraepithelial neoplasia.